Aldevron is scheduled to present, exhibit and conduct one-on-one meetings at the Biotechnology Innovation Organization’s (BIO) International Convention, June 3 – 6, 2019, in Philadelphia. Aldevron’s James Brown, VP Corporate Development, is speaking on standardized helper plasmids for viral vector production.
“We are pleased to present our data at BIO,” said Brown. “Our results demonstrate the ability to manufacture plasmid DNA at 300 L scale and show that standardized plasmids can be used for viral vector production. These results combined with our recently announced 1,000 L fermentation expansion make standardized plasmids an attractive alternative to custom manufacturing. The immediate availability and lower cost to operate of these products enable a faster and more economical path for gene therapy product development.”
Tuesday, June 4
11:20 – 11:40 a.m. ET
BioProcess International Theater
Booth #3211, in the BioProcess Zone of the BIO exhibit hall
Aldevron will also exhibit at the convention at booth 4318. The convention program will consist of over 1,500 education sessions for over 16,000 attendees from 74 countries. BIO represents more than 1,100 organizations in the biotechnology field.
Brown will also be participating in Phacilitate’s upcoming free webinar in which Aldevron, Oxford Genetics and Asklepios BioPharmaceutical will be discussing large scale production of standardized plasmids.